Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Trends in Biotechnology|January 26, 2022
Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivityErica R Vander Mause, Djordje Atanackovic, Carol S Lim, et al.Therapeutic Delivery|December 17, 2019
Advances in delivery vectors for gene therapy in liver cancerKatherine E Redd Bowman, Phong Lu, Erica R Vander Mause, et al.Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|November 18, 2022
Ellman's reagent prevents dephosphorylation of histones during isolation of mitotic chromosomesJames R Paulson, Erica R Vander Mause, Elizabeth Dillinger, et al.Journal of Ovarian Research|May 17, 2019
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53Phong Lu, Erica R Vander Mause, Katherine E Redd Bowman, et al.Molecular Pharmaceutics|December 9, 2022
p53-Bad* Fusion Gene Therapy Induces Apoptosis In Vitro and Reduces Zebrafish Tumor Burden in Hepatocellular CarcinomaKatherine E Redd Bowman, Lisa Ahne, Liam O'Brien, et al.Molecular Pharmaceutics|June 27, 2019
p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene TherapyPhong Lu, Katherine E Redd Bowman, Sarah M Brown, et al.Nature Communications|February 9, 2020
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricideSabarinath V Radhakrishnan, Tim Luetkens, Sandra D Scherer, et al.Science Translational Medicine|July 19, 2023
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicityErica R Vander Mause, Jillian M Baker, Kenneth A Dietze, et al.Pageof 1